国药股份 (600511)

China National Medicines Corporation Ltd.

ASH

Tags

MSCI Mid Cap IndexSSE Mixed-Ownership Reform IndexCSI Central State-Owned Enterprises IndexLow Price-to-Earnings RatioInsurance Heavy PositionsPension FundsCold Chain LogisticsPharmaceuticals and HealthcarePharmaceutical CommerceGuozheng Value IndexSmall Cap ValueWholesaleBiological VaccinesSocial Security Fund Heavy PositionsHigh-Performing StocksMargin Trading and Securities LendingHigh Accounts Receivable

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 75450.30
  • Circulating A-Shares(W): 55334.64
  • Earnings Per Share(RMB): 1.9778
  • Net Assets Per Share(RMB): 23.9132
  • Operating Revenue(W RMB): 3938130.14
  • Total Profit(W RMB): 193374.25
  • **Net Profit Attributable to Parent(W RMB) **: 149226.53
  • Net Profit Growth Rate(%): 0.74
  • Weighted Return on Equity(%): 8.5000
  • Operating Cash Flow Per Share(RMB): -2.7180
  • Undistributed Profit Per Share(RMB): 18.9248
  • Capital Reserve Per Share(RMB): 3.1131

2. Main Business

The main business covers:

  • Pharmaceutical Distribution
  • Pharmaceutical Manufacturing
  • Pharmaceutical Logistics

3. Company Basic Information

  • Company Name: Sinopharm Group Co., Ltd.
  • Listing Date: 2002-11-27
  • Industry: Pharmaceutical & Healthcare - Pharmaceutical Commerce
  • Address: 6-9F, West Tower, Building 7, No. 8 Yongdingmen Xibinhe Road, Dongcheng District, Beijing
  • Website: http://www.sinopharm.com/
  • Company Profile: The company was established with the approval of the State Economic and Trade Commission. China National Pharmaceutical Group Co., Ltd. acted as the main sponsor, jointly established with Sinopharm Group Shanghai Medical Devices Co., Ltd., Tianjin Qiyu Medical Devices Co., Ltd., Guangzhou Nanfang Medical Devices Company, and Beijing Renkang Medical Devices Business Department.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Sinopharm Group Co., Ltd. Corporate Legal Person 21168.52 38.26
2 National Social Security Fund 113 Portfolio Social Security Fund 2281.76 4.12
3 New China Life Insurance Co., Ltd. - Traditional - General Insurance Product - 018L-CT001 Shanghai Insurance 2033.20 3.67
4 Basic Pension Insurance Fund 802 Portfolio Social Security Fund 2031.80 3.67
5 New China Life Insurance Co., Ltd. - Dividend - Individual Dividend - 018L-FH002 Shanghai Insurance 1333.30 2.41
6 Beijing Kangen Pharmaceutical Co., Ltd. Corporate Legal Person 1023.62 1.85
7 Beijing Changxin Yida Investment Advisory Co., Ltd. Corporate Legal Person 724.26 1.31
8 Hong Kong Securities Clearing Company Ltd. Northbound Capital 689.81 1.25
9 New China Life Insurance Co., Ltd. - Dividend - Group Dividend - 018L-FH001 Shanghai Insurance 583.84 1.06
10 CSI 500 Exchange Traded Open End Index Securities Investment Fund Fund 550.70 1.00

5. Concept Sectors

  • Biological Vaccine
  • Cold Chain Logistics
  • Margin Trading & Securities Lending
  • Heavily Held by Insurance
  • Low P/E Ratio
  • High-Performing Stock
  • Heavily Held by Social Security Funds
  • Pension Fund
  • MSCI Mid Cap
  • High Accounts Receivable
  • Small Cap Value
  • SZSE Value Index
  • CSI Central SOEs
  • SSE Mixed-Ownership Reform

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information